Page last updated: 2024-08-21

pyrazines and kd 5170

pyrazines has been researched along with kd 5170 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Feng, R; Hager, JH; Hassig, CA; Lentzsch, S; Ma, H; Mapara, MY; Payne, JE; Smith, ND	1

Other Studies

1 other study(ies) available for pyrazines and kd 5170

Article	Year
KD5170, a novel mercaptoketone-based histone deacetylase inhibitor, exerts antimyeloma effects by DNA damage and mitochondrial signaling. Molecular cancer therapeutics, 2008, Volume: 7, Issue:6 Topics: Acetylation; Animals; Antineoplastic Agents; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Boronic Acids; Bortezomib; Caspases; Cell Line, Tumor; DNA Damage; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histones; Humans; Ketones; Membrane Potential, Mitochondrial; Mice; Mitochondria; Multiple Myeloma; Oxidative Stress; Protein Transport; Pyrazines; Pyridines; Signal Transduction; Sulfonamides; TNF-Related Apoptosis-Inducing Ligand; Xenograft Model Antitumor Assays	2008

Article

Year

KD5170, a novel mercaptoketone-based histone deacetylase inhibitor, exerts antimyeloma effects by DNA damage and mitochondrial signaling.

Molecular cancer therapeutics, 2008, Volume: 7, Issue:6

Topics: Acetylation; Animals; Antineoplastic Agents; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Boronic Acids; Bortezomib; Caspases; Cell Line, Tumor; DNA Damage; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histones; Humans; Ketones; Membrane Potential, Mitochondrial; Mice; Mitochondria; Multiple Myeloma; Oxidative Stress; Protein Transport; Pyrazines; Pyridines; Signal Transduction; Sulfonamides; TNF-Related Apoptosis-Inducing Ligand; Xenograft Model Antitumor Assays

2008